BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20954650)

  • 1. Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
    Patel VC; Lazzarini AM
    Orthopedics; 2010 Oct; 33(10):775. PubMed ID: 20954650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
    Goddard MS; Reid KR; Johnston JC; Khanuja HS
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
    Capeci CM; Tejwani NC
    J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
    Grady MK; Watson JT; Cannada LK
    Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical forearm fractures associated with long-term use of bisphosphonate.
    Moon J; Bither N; Lee T
    Arch Orthop Trauma Surg; 2013 Jul; 133(7):889-92. PubMed ID: 23619919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
    Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
    J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
    Yli-Kyyny TT; Tamminen I; Kröger H
    Orthopedics; 2010 Dec; 33(12):867. PubMed ID: 21117559
    [No Abstract]   [Full Text] [Related]  

  • 8. Bilateral femur fractures associated with short-term bisphosphonate use.
    Rifai A; Pourtaheri S; Carbone A; Callaghan JJ; Stadler CM; Record N; Issa K
    Orthopedics; 2015 Feb; 38(2):e139-42. PubMed ID: 25665120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral atypical femur fractures without bisphosphonate exposure.
    Szolomayer LK; Ibe IK; Lindskog DM
    Skeletal Radiol; 2017 Feb; 46(2):241-247. PubMed ID: 27900455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
    Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
    Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.
    Sasaki S; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y
    J Bone Miner Metab; 2012 Sep; 30(5):561-7. PubMed ID: 22610061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Femur fractures caused by long-term bisphosphonate therapy].
    Somford MP; Thomassen BJ; Draijer WF
    Ned Tijdschr Geneeskd; 2010; 154():A1218. PubMed ID: 20619008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.
    Nieves JW; Cosman F
    Curr Osteoporos Rep; 2010 Mar; 8(1):34-9. PubMed ID: 20425089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
    Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
    J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
    Reddy SV; Gupta SK
    Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
    Ng YH; Gino PD; Lingaraj K; Das De S
    Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of bisphosphonate-associated femoral fractures.
    Shkolnikova J; Flynn J; Choong P
    ANZ J Surg; 2013 Mar; 83(3):175-81. PubMed ID: 23216704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].
    Ing Lorenzinit K; Meier R; Suva D; Dayer P; Desmeules J; Peter R
    Rev Med Suisse; 2012 Jun; 8(344):1238-42. PubMed ID: 22730621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.